Gilead Sciences Slumps to 89th in Trading Volume as Bank of America Boosts Price Target

On April 7, 2025, Gilead Sciences (GILD) experienced a decline of 1.61%, marking its second consecutive day of losses, with a total decrease of 6.11% over the past two days. The trading volume for the day was 14.86 billion, placing it at the 89th position in the daily stock market rankings.

Bank of America has increased its price target for Gilead Sciences from $116.00 to $126.00 and maintained a "buy" rating for the stock. This adjustment reflects a positive outlook on the company's future performance and potential for growth.

BofA Securities has also revised its price target for Gilead Sciences, raising it from $116.00 to $126.00 while keeping the "buy" rating intact. This move underscores the firm's confidence in the company's prospects and its ability to deliver value to investors.